Cancer Resource Center of the Desert – Trademark Portfolio
Entity Type: 03
Cancer Resource Center of the Desert holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 4 filings in this category. The portfolio also extends into Class 25 (Clothing) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include VIVORWEAR, SURVIVORWEAR, and ALTERNATIVE WEARABLE. The owner is based in El Centro, CA.
444 So. 8th Street, Ste B-3
El Centro, CA 92243
Showing of trademarks Trademarks
Trademark Classifications
Cancer Resource Center of the Desert's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Cancer Resource Center of the Desert have?
Cancer Resource Center of the Desert has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 cancelled.
What trademark classes does Cancer Resource Center of the Desert file in?
Cancer Resource Center of the Desert files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 25 (Clothing), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Cancer Resource Center of the Desert's most well-known trademarks?
Cancer Resource Center of the Desert's registered trademark portfolio includes well-known marks such as VIVORWEAR, SURVIVORWEAR, and ALTERNATIVE WEARABLE. These are among 3 currently registered trademarks in the portfolio.
What is Cancer Resource Center of the Desert's trademark registration success rate?
Cancer Resource Center of the Desert has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.